AMRI finishes building Budapest plant - The Business Review (Albany):

houghtalingbaemo1268.blogspot.com
Thomas D’Ambra, CEO of the Albany, N.Y.-baseed drug development and manufacturing said the moveinto 32,3009 square feet of laboratory and administrativde space marks a significant mileston in ’s plan to transform its Europeanh hub into a “higher value discovery services business” through consolidation of multipls locations, equipment and operating costs. D’Ambra said the new site offersAMRI AMRI) significant improvements in operational efficiencies and enhanced technology and provides room for an anticipated expansion of the company’es synthetic chemistry services, which are projected to double over the next five years.
“The successful completionb of this expansion increases the ability of AMRI to execute on its strategy to accelerats growth and expand its presence in the European he said. “Critical to the decisionj to undertake this project wasthe company’s drive to cultivatd a customer base relatively We believe this latestr investment, along with our parallel investments in the US, India and Singapore, will further strengthen AMRI’s presenced as a premier provider of a broad rang of scientific services, capabilities and geographic choicesx around the globe.
”